Glenn van Zutphen talks to Dr. Andreas Schmidt, CEO of Singapore start-up Proteona Pte. Ltd. about how their scientists are searching for protective antibodies that could potentially save immunocompromised patients who contract Covid-19. Surprising new alliances are forming in the global race for effective solutions.

<p>Glenn van Zutphen talks to <strong>Dr. Andreas Schmidt, CEO of Singapore start-up Proteona Pte. Ltd. </strong>about how their scientists are searching for protective antibodies that could potentially save immunocompromised patients who contract Covid-19. Surprising new alliances are forming in the global race for effective solutions.</p>